Biotechnology industries
Molecular Diagnostics at the Point of Care Market on the Brink of Unprecedented Growth
The Molecular Diagnostics at the Point of Care market is poised for significant growth over the next five years, driven by advancements in technology and increasing demand for rapid, reliable testing solutions available at the patient's bedside. This burgeoning market segment is being propelled by major players consistently